238 related articles for article (PubMed ID: 12874455)
1. Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus.
Araki S; Ng DP; Krolewski B; Wyrwicz L; Rogus JJ; Canani L; Makita Y; Haneda M; Warram JH; Krolewski AS
J Am Soc Nephrol; 2003 Aug; 14(8):2015-24. PubMed ID: 12874455
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the protein kinase C-beta gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria.
Araki S; Haneda M; Sugimoto T; Isono M; Isshiki K; Kashiwagi A; Koya D
Diabetes Care; 2006 Apr; 29(4):864-8. PubMed ID: 16567829
[TBL] [Abstract][Full Text] [Related]
3. No support for association of protein kinase C, beta 1 (PRKCB1) gene promoter polymorphisms c.-1504C>T and c.-546C>G with diabetic nephropathy in Type 1 diabetes.
Pettigrew KA; McKnight AJ; Martin RJ; Patterson CC; Kilner J; Sadlier D; Maxwell AP; Savage DA;
Diabet Med; 2008 Sep; 25(9):1127-9. PubMed ID: 18937679
[No Abstract] [Full Text] [Related]
4. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism.
Zanchi A; Moczulski DK; Hanna LS; Wantman M; Warram JH; Krolewski AS
Kidney Int; 2000 Feb; 57(2):405-13. PubMed ID: 10652017
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus.
Moczulski DK; Scott L; Antonellis A; Rogus JJ; Rich SS; Warram JH; Krolewski AS
Diabet Med; 2000 Feb; 17(2):111-8. PubMed ID: 10746480
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C beta (PRKCB1) and pigment epithelium derived factor (PEDF) gene polymorphisms and diabetic retinopathy in a south Indian cohort.
Uthra S; Raman R; Mukesh BN; Rajkumar SA; Kumari PR; Lakshmipathy P; Gnanamoorthy P; Sharma T; McCarty CA; Kumaramanickavel G
Ophthalmic Genet; 2010 Mar; 31(1):18-23. PubMed ID: 20141354
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.
Ma RC; Tam CH; Wang Y; Luk AO; Hu C; Yang X; Lam V; Chan AW; Ho JS; Chow CC; Tong PC; Jia W; Ng MC; So WY; Chan JC
JAMA; 2010 Aug; 304(8):881-9. PubMed ID: 20736472
[TBL] [Abstract][Full Text] [Related]
8. Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population.
Chen F; Li YM; Yang LQ; Zhong CG; Zhuang ZX
IUBMB Life; 2016 Jul; 68(7):516-25. PubMed ID: 27192959
[TBL] [Abstract][Full Text] [Related]
9. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I--converting enzyme gene.
Doria A; Warram JH; Krolewski AS
Diabetes; 1994 May; 43(5):690-5. PubMed ID: 7909524
[TBL] [Abstract][Full Text] [Related]
10. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies.
Araki S; Moczulski DK; Hanna L; Scott LJ; Warram JH; Krolewski AS
Diabetes; 2000 Dec; 49(12):2190-5. PubMed ID: 11118024
[TBL] [Abstract][Full Text] [Related]
11. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
[TBL] [Abstract][Full Text] [Related]
12. Association between variation in the actin-binding gene caldesmon and diabetic nephropathy in type 1 diabetes.
Conway BR; Maxwell AP; Savage DA; Patterson CC; Doran PP; Murphy M; Brady HR; Fogarty DG
Diabetes; 2004 Apr; 53(4):1162-5. PubMed ID: 15047636
[TBL] [Abstract][Full Text] [Related]
13. Association of VEGF-1499C-->T polymorphism with diabetic nephropathy in type 1 diabetes mellitus.
McKnight AJ; Maxwell AP; Patterson CC; Brady HR; Savage DA
J Diabetes Complications; 2007; 21(4):242-5. PubMed ID: 17616354
[TBL] [Abstract][Full Text] [Related]
14. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Bhansali A; Sud K; Khullar M
DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684
[TBL] [Abstract][Full Text] [Related]
15. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
Zhang D; Ma J; Brismar K; Efendic S; Gu HF
J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
[TBL] [Abstract][Full Text] [Related]
16. The C825T polymorphism in the human G-protein beta3 subunit gene is not associated with diabetic nephropathy in Type I diabetes mellitus.
Fogarty DG; Zychma MJ; Scott LJ; Warram JH; Krolewski AS
Diabetologia; 1998 Nov; 41(11):1304-8. PubMed ID: 9833937
[TBL] [Abstract][Full Text] [Related]
17. Associations of TCF7L2 gene polymorphisms with the risk of diabetic nephropathy: A case-control study.
Zhuang Y; Niu F; Liu D; Sun J; Zhang X; Zhang J; Guo S
Medicine (Baltimore); 2018 Oct; 97(40):e8388. PubMed ID: 30290587
[TBL] [Abstract][Full Text] [Related]
18. Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect.
Mlynarski WM; Placha GP; Wolkow PP; Bochenski JP; Warram JH; Krolewski AS
Diabetes; 2005 Nov; 54(11):3331-5. PubMed ID: 16249462
[TBL] [Abstract][Full Text] [Related]
19. Common polymorphisms of the PAI1 gene do not play a major role in the development of diabetic nephropathy in Type 1 diabetes.
Martin RJ; Savage DA; Patterson CC; Brady HR; Maxwell AP
Diabet Med; 2007 Mar; 24(3):259-65. PubMed ID: 17263760
[TBL] [Abstract][Full Text] [Related]
20. Correlation Between Polymorphisms of the
Sun Y; Wang J; Meng Y
Genet Test Mol Biomarkers; 2021 Jun; 25(6):387-398. PubMed ID: 34152844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
